Caris Life Sciences President Spetzler David Baxley exercised Options for 1,250,000 shares at $2.44 per share. For investors, the transactions identify the exercise cost, sale-price range and resulting holdings, including 1,182,871 shares after sales and no remaining derivative securities.
Key Highlights
- Baxley owned 1,302,083 shares after the option exercises.
- The derivative securities were exercised at $0 per share.
- The transactions covered both share sales and derivative securities.
Caris Life Sciences, Inc. (NASDAQ: CAI) President Spetzler David Baxley exercised options for 1,250,000 shares at $2.44 per share. The transactions were dated September 3 and September 4, with Baxley’s holdings reaching 1,302,083 shares after the exercises.
Baxley Reports Share Sales and Option Exercises
Separate transactions covered sales of 597,212 shares at prices ranging from $24.76 to $25.32 per share. Baxley’s reported share ownership after those sales was 1,182,871 shares. The transactions also covered 1,250,000 derivative securities exercised at $0 per share. The derivative securities position was reduced to none after those exercises. The filing identifies Baxley as president of Caris Life Sciences, Inc. and reports the share exercises, derivative securities exercises and sales between September 3 and September 4. The filing reported an exercise price of $2.44 per share and sale prices ranging from $24.76 to $25.32 per share. The ownership figures were reported separately after the exercises and after the sales.
FAQs
Q: How many Caris Life Sciences shares did David Baxley exercise?
A: Caris Life Sciences President David Baxley exercised options for 1,250,000 shares at $2.44 per share in transactions dated September 3 and September 4.
Q: How many Caris Life Sciences shares did David Baxley sell?
A: David Baxley sold 597,212 Caris Life Sciences shares in three separate transactions. The filing reported sale prices ranging from $24.76 to $25.32 per share.
Q: How many shares did David Baxley own after the transactions?
A: Baxley owned 1,302,083 shares after the option exercises. The filing reported that following the sales, his ownership was 1,182,871 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.